Quantification of HIV in semen: Correlation with antiviral treatment and immune status

被引:170
作者
Vernazza, PL
Gilliam, BL
Dyer, J
Fiscus, SA
Eron, JJ
Frank, AC
Cohen, MS
机构
[1] UNIV N CAROLINA, DEPT MED, CHAPEL HILL, NC USA
[2] UNIV N CAROLINA, DEPT MICROBIOL & IMMUNOL, CHAPEL HILL, NC USA
[3] KANTONSSPITAL, DEPT MED, ST GALLEN, SWITZERLAND
关键词
semen; viral load; HIV RNA; infectivity; culture;
D O I
10.1097/00002030-199708000-00006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective: This study examined the concentration of HIV in semen and the effec Methods: Semen samples from 101 men at different stages of the disease were evaluated by quantitative HIV culture and HIV RNA detection. Blood plasma samples were available from 56 patients. The effects of CD4 and CD8 count, blood plasma RNA levels, treatment status and clinical staging on the shedding of HIV were evaluated. Results: HIV RNA levels in semen correlated with quantitative HIV culture of: seminal cells and a strong association of positive seminal cell culture with high RNA levels was observed. CD4 count and antiviral treatment were inversely correlated with the concentration of HIV in semen. Blood plasma HIV RNA values were correlated with HIV RNA levels in semen, although some patients had highly discrepant results. Conclusions: The strong correlation between seminal cell culture and concentration of HIV RNA in seminal plasma suggested that HIV detected in seminal plasma was released by productively infected cells in the male genital tract. The study showed that the concentration of HIV in semen, which was likely to be correlated with HIV infectivity, was a function of the immune status of the HIV-infected individual. The results suggested that antiviral therapy may have reduced the concentration of HIV in semen.
引用
收藏
页码:987 / 993
页数:7
相关论文
共 35 条
[1]   EFFECTS OF DISEASE STAGE AND ZIDOVUDINE THERAPY ON THE DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN SEMEN [J].
ANDERSON, DJ ;
OBRIEN, TR ;
POLITCH, JA ;
MARTINEZ, A ;
SEAGE, GR ;
PADIAN, N ;
HORSBURGH, CR ;
MAYER, KH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (20) :2769-2774
[2]  
ANDERSON R M, 1991
[3]  
*CDCP, 1995, MMWR-MORBID MORTAL W, V44, P929
[4]  
Centers for Disease Control, 1993, MMWR Morb Mortal Wkly Rep, V41, P1
[5]   A CLUSTER OF HIV INFECTION AMONG HETEROSEXUAL PEOPLE WITHOUT APPARENT RISK-FACTORS [J].
CLUMECK, N ;
TAELMAN, H ;
HERMANS, P ;
PIOT, P ;
SCHOUMACHER, M ;
DEWIT, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (21) :1460-1462
[7]   Probability of heterosexual transmission of HIV: Relationship to the number of unprotected sexual contacts [J].
Downs, AM ;
DeVincenzi, I ;
Costigliola, P ;
Ricchi, E ;
Chiodo, F ;
Roumeliotou, A ;
Papaevangelou, G ;
Coutinho, RA ;
vanHaastrecht, HJA ;
Brettle, R ;
Robertson, R ;
Kraus, M ;
Heckmann, W ;
Saracco, A ;
Sacco, OL ;
Johnson, AM ;
Vandenbruaene, M ;
Goeman, J ;
Cardoso, J ;
Sobel, A ;
GonzalezLahoz, J ;
AndresMedina, R ;
Casabona, J ;
Tor, J ;
AncellePark, RA ;
Brunet, JB .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1996, 11 (04) :388-395
[8]  
Dyer JR, 1997, AIDS, V11, P543
[9]   Quantitation of human immunodeficiency virus type 1 RNA in cell free seminal plasma: Comparison of NASBA(TM) with Amplicor(TM) reverse transcription-PCR amplification and correlation with quantitative culture [J].
Dyer, JR ;
Gilliam, BL ;
Eron, JJ ;
Grosso, L ;
Cohen, MS ;
Fiscus, SA .
JOURNAL OF VIROLOGICAL METHODS, 1996, 60 (02) :161-170
[10]  
GILLIAM BL, 1997, IN PRESS J ACQUIR IM